Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. METHODS: In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. RESULTS: The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group (P=0.003), with a significant difference among patients 25 years of age or older that favored the continuous-monitoring group (mean difference in change, -0.53%; 95% confidence interval [CI], -0.71 to -0.35; P<0.001). The between-group difference was not significant among those who were 15 to 24 years of age (mean difference, 0.08; 95% CI, -0.17 to 0.33; P=0.52) or among those who were 8 to 14 years of age (mean difference, -0.13; 95% CI, -0.38 to 0.11; P=0.29). Secondary glycated hemoglobin outcomes were better in the continuous-monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. CONCLUSIONS: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large trial of rt-CGM in people with type 1 diabetes showing significant reductions in HbA 1c in adults (159), improved glucose control was not seen in children (ages 8 to 14 years) or adolescents and young adults (ages 15 to 24 years).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Most randomized controlled trials (RCTs) in adults with type 1 diabetes show that rt-CGM leads to lower HbA 1c (156-159) and reduced time in the hypoglycemic range (160,161).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [22]
In the citing paper
“Tamborlane and colleagues91 reported that a real-time continuous glucose monitoring system decreased the amount of time spent in hypoglycaemia (<4 mmol/L [70 mg/dL]) and lowered HbA1C when used by patients an average of 6 days a week.”
From Type 1 diabetes (2014) · cites this paper as [91]
In the citing paper
“In this study, the degree of HbA1C reduction directly correlated with higher HbA1C concentrations before beginning continuous glucose monitoring.”
From Type 1 diabetes (2014) · cites this paper as [91]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEpidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Research works printed but not linked: 1
- Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley, 1987.
Cited by
Items 301–400 of 1,001
Agarwal, S., Crespo-Ramos, G., Long, J. A., & Miller, V. A. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0075 · Cited by 80
Real-Life Utilization of Real-Time Continuous Glucose Monitoring: The Complete Picture
Ramchandani, N., Arya, S., Ten, S., & Bhandari, S. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500407 · Cited by 82
A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control
Kovatchev, B. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.04.008 · Cited by 80
Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm
Keenan, D. B., Cartaya, R., & Mastrototaro, J. J. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400114 · Cited by 79
Rizzo, M. (2011) · JAMA · doi:10.1001/jama.2011.252 · Cited by 78
The role of structured education in the management of hypoglycaemia
Iqbal, A., & Heller, S. R. (2018) · Diabetologia · doi:10.1007/s00125-017-4334-z · Cited by 78
Markowitz, J. T., Pratt, K., Aggarwal, J., Volkening, L. K., & Laffel, L. M. B. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0201 · Cited by 80
Волков, И. В., Radchenko, G., & Tchernykh, A. N. (2021) · Programming and Computer Software · doi:10.1134/s0361768821080284 · Cited by 98
Zisser, H. C., Bailey, T. S., Schwartz, S., Ratner, R. E., & Wise, J. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300519 · Cited by 76
Continuous glucose monitoring in patients with type 1 diabetes using insulin injections
Foster, N. C., Miller, K. M., Tamborlane, W. V., Bergenstal, R. M., & Beck, R. W. (2016) · Diabetes Care · doi:10.2337/dc16-0207 · Cited by 76
Duckworth, C., Guy, M. J., Kumaran, A., O’Kane, A. A., Ayobi, A., Chapman, A., Marshall, P., & Boniface, M. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221103561 · Cited by 75
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use
Liebl, A., Henrichs, H. R., Heinemann, L., Freckmann, G., Biermann, E., Thomas, A., & for the Continuous Glucose Monitoring Working Group of the Working Group Diabetes Technology of the German Diabetes Association (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700227 · Cited by 77
Cunningham, N. R., Vesco, A. T., Dolan, L. M., & Hood, K. K. (2011) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsq071 · Cited by 77
“technologies have been made (Tamborlane et al., 2008), adolescents with type 1 diabetes continue to exhibit suboptimal glycemic control (Danne et al.”
BackgroundMcQueen, R. B., Ellis, S. L., Campbell, J. D., Nair, K. V., & Sullivan, P. W. (2011) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-9-13 · Cited by 74
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement
Bartlett, S. T., Markmann, J. F., Johnson, P., Korsgren, O., Hering, B. J., Scharp, D., Kay, T. W. H., Bromberg, J., Odorico, J. S., Weir, G. C., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001055 · Cited by 75
Bruttomesso, D., Laviola, L., Avogaro, A., Bonora, E., Del Prato, S., Frontoni, S., Orsi, E., Rabbone, I., Sesti, G., & Purrello, F. (2019) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.01.018 · Cited by 72
Snell‐Bergeon, J. K., Roman, R., Rodbard, D., Garg, S., Maahs, D. M., Schauer, I. E., Bergman, B. C., Kinney, G. L., & Rewers, M. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03127.x · Cited by 74
Quality of Life and Technology: Impact on Children and Families With Diabetes
Hirose, M., Beverly, E. A., & Weinger, K. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0313-4 · Cited by 71
Continuous Glucose Monitoring: Current Use and Future Directions
DeSalvo, D., & Buckingham, B. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0398-4 · Cited by 73
Morbidity and Mortality of Diabetic Ketoacidosis With and Without Insulin Pump Care
Realsen, J., Goettle, H., & Chase, H. P. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0161 · Cited by 73
Closed-Loop System in the Management of Diabetes: Past, Present, and Future
Shah, V. N., Shoskes, A., Tawfik, B., & Garg, S. K. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0193 · Cited by 84
Golden, S. H., & Sapir, T. (2012) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2012.18.s6-a.1 · Cited by 100
Recurrent Hypoglycemia Exacerbates Cerebral Ischemic Damage in Streptozotocin-Induced Diabetic Rats
Dave, K. R., Tamariz, J., Desai, K., Brand, F. J., Liu, A., Saul, I., Bhattacharya, S. K., & Pileggi, A. (2011) · Stroke · doi:10.1161/strokeaha.110.594937 · Cited by 74
Giani, E., Snelgrove, R., Volkening, L. K., & Laffel, L. M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816676280 · Cited by 71
Floyd, B., Chandra, P., Hall, S., Phillips, C., Alema-Mensah, E., Strayhorn, G., Ofili, E. O., & Umpierrez, G. E. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600513 · Cited by 70
Bailey, T., Zisser, H., & Chang, A. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0075 · Cited by 71
Joubert, M., & Reznik, Y. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.010 · Cited by 70
Persistence of Individual Variations in Glycated Hemoglobin
Wilson, D. M., Xing, D., Cheng, J., Beck, R. W., Hirsch, I., Kollman, C., Laffel, L., Lawrence, J. M., Mauras, N., Ruedy, K. J., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1661 · Cited by 71
Uettwiller, F., Chemin, A., Bonnemaison, É., Favrais, G., Saliba, É., & Labarthe, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116255 · Cited by 69
Szypowska, A., Ramotowska, A., Dżygało, K., & Golicki, D. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0642 · Cited by 69
A Review of Closed-Loop Algorithms for Glycemic Control in the Treatment of Type 1 Diabetes
El Youssef, J., Castle, J., & Ward, W. K. (2009) · Algorithms · doi:10.3390/a2010518 · Cited by 69
The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older
Polonsky, W. H., Peters, A. L., & Hessler, D. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816643542 · Cited by 69
Berard, L. D., Siemens, R., & Woo, V. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.007 · Cited by 69
Reddy, N., Verma, N., & Dungan, K. M. (2020) · MDText.com, Inc. eBooks · Cited by 108
Management of diabetes mellitus in infants
Karges, B., Meißner, T., Icks, A., Kapellen, T. M., & Holl, R. W. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.204 · Cited by 69
A fluorescence lifetime-based fibre-optic glucose sensor using glucose/galactose-binding protein
Saxl, T., Khan, F., Ferla, M. P., Birch, D. J. S., & Pickup, J. C. (2010) · The Analyst · doi:10.1039/c0an00430h · Cited by 69
Aschner, P. J., Horton, E., Leiter, L. A., Munro, N. M., Skyler, J. S., & Management*, O. B. O. T. G. P. F. E. D. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02296.x · Cited by 76
Tauschmann, M., Cardona‐Hernandez, R., DeSalvo, D. J., Hood, K. K., Лаптев, Д. Н., Olinder, A. L., Wheeler, B. J., & Smart, C. E. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543156 · Cited by 82
Facchinetti, A., Sparacino, G., & Cobelli, C. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400102 · Cited by 67
Hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00023-7 · Cited by 74
Neylon, O. M., O’Connell, M. A., Skinner, T. C., & Cameron, F. J. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2392 · Cited by 75
Mulinacci, G., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0257 · Cited by 66
Ansari, M. A., Chauhan, W., Shoaib, S., Alyahya, S. A., Ali, M., Ashraf, H., Alomary, M. N., & Al-Suhaimi, E. A. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01369-3 · Cited by 73
A review of artificial pancreas technologies with an emphasis on bi‐hormonal therapy
Bakhtiani, P. A., Zhao, L. M., El Youssef, J., Castle, J. R., & Ward, W. K. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12107 · Cited by 65
Wilinska, M. E., Budiman, E. S., Taub, M. B., Elleri, D., Allen, J. M., Acerin, C. L. I., Dunger, D. B., & Hovorka, R. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300514 · Cited by 65
Wood, A., O'Neal, D., Furler, J., & Ekinci, E. I. (2018) · Internal Medicine Journal · doi:10.1111/imj.13770 · Cited by 67
Use of Mobile Health Technology in the Prevention and Management of Diabetes Mellitus
Hartz, J., Yingling, L., & Powell-Wiley, T. M. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0796-8 · Cited by 64
Time in range centered diabetes care
Dovč, K., & Battelino, T. (2021) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.30.1 · Cited by 70
Boscari, F., Galasso, S., Facchinetti, A., Marescotti, M. C., Vallone, V., Amato, A. M. L., Avogaro, A., & Bruttomesso, D. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.023 · Cited by 72
Vigersky, R. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814565661 · Cited by 63
Continuous Glucose Monitoring: An Overview of Its Development
Skyler, J. S. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0045 · Cited by 71
Yang, J., Yang, X., Zhao, D., Wang, X., Wei, W., & Yuan, H. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13394 · Cited by 62
Dehghani Zahedani, A., Shariat Torbaghan, S., Rahili, S., Karlin, K., Scilley, D., Thakkar, R., Saberi, M., Hashemi, N., Perelman, D., Aghaeepour, N., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01081-3 · Cited by 62
Facchinetti, A., Favero, S., Sparacino, G., & Cobelli, C. (2013) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2012.2227256 · Cited by 62
The Use of Insulin Pumps in Youth with Type 1 Diabetes
Maahs, D. M., Horton, L. A., & Chase, H. P. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0161 · Cited by 62
Tay, J., Thompson, C. H., & Brinkworth, G. D. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-121214-104422 · Cited by 61
Pettus, J., Price, D. A., & Edelman, S. V. (2015) · Endocrine Practice · doi:10.4158/ep14520.or · Cited by 68
Continuous Glucose Monitoring and Global Reimbursement: An Update
Graham, C. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0096 · Cited by 62
Diabetes Research in Children Network (DirecNet) Study Group (2009) · Diabetes Care · doi:10.2337/dc08-2298 · Cited by 61
Kieu, A., King, J., Govender, R. D., & Östlundh, L. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211070855 · Cited by 73
Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2011) · Diabetes Care · doi:10.2337/dc10-1111 · Cited by 61
Jung, H. S., Kim, H. I., Kim, M. J., Yoon, J. W., Ahn, H. Y., Cho, Y. M., Oh, K., Joo, K. W., Lee, J. G., Kim, S. Y., et al. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0067 · Cited by 68
Pai, P. P., De, A., & Banerjee, S. (2017) · IEEE Transactions on Instrumentation and Measurement · doi:10.1109/tim.2017.2761237 · Cited by 65
Rickels, M. R., Peleckis, A. J., Dalton-Bakes, C., Naji, J. R., Ran, N. A., Nguyen, H.-L., O’Brien, S., Chen, S., Lee, I., & Schutta, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01516 · Cited by 60
“70% were dropped because lower compliance has not been associated with any benefit of real-time CGM to glycemic control (12).”
BackgroundMethodPlasmonic contact lens materials for glucose sensing in human tears
Lee, W., Koh, E. H., Kim, D., Park, S., & Jung, H. S. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130297 · Cited by 63
Barrett, C., Dawson, K., O’Mahony, C., & O'Riordan, A. J. (2015) · ECS Journal of Solid State Science and Technology · doi:10.1149/2.0141510jss · Cited by 60
Facchinetti, A., Sparacino, G., & Cobelli, C. (2011) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2011.2161083 · Cited by 58
Forlenza, G. P., Buckingham, B., & Maahs, D. M. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.015 · Cited by 58
Hemoglobin A1c and Mean Glucose in Patients With Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2011) · Diabetes Care · doi:10.2337/dc10-1054 · Cited by 61
Real-world evidence of automated insulin delivery system use
Considine, E. G., & Sherr, J. L. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0442 · Cited by 59
Choe, H. J., Rhee, E.-J., Won, J. C., Park, K. S., Lee, W.-Y., & Cho, Y. M. (2022) · Diabetes Care · doi:10.2337/dc22-0764 · Cited by 59
Continuous glucose monitoring pilot in low-income type 1 diabetes patients
Sequeira, P. A., Montoya, L., Ruelas, V., Xing, D., Chen, V., Beck, R., & Peters, A. L. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0072 · Cited by 59
Erie, C., Van Name, M. A., Weyman, K., Weinzimer, S. A., Finnegan, J., Sikes, K., Tamborlane, W. V., & Sherr, J. L. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12518 · Cited by 57
CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring
Messer, L. H., Cook, P. F., Tanenbaum, M. L., Hanes, S., Driscoll, K. A., & Hood, K. K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819832909 · Cited by 58
RETRACTED: Carbon nanomaterials: A growing tool for the diagnosis and treatment of diabetes mellitus
Jiang, H., Xia, C., Lin, J., Garalleh, H. A., Alalawi, A., & Pugazhendhi, A. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115250 · Cited by 63
RetractedUse of Continuous Glucose Monitoring as an Outcome Measure in Clinical Trials
Beck, R. W., Calhoun, P., & Kollman, C. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0079 · Cited by 58
Coughlin, L. N., Nahum-Shani, I. B., Philyaw-Kotov, M. L., Bonar, E. E., Rabbi, M., Klasnja, P., Murphy, S. A., & Walton, M. A. (2021) · JMIR mhealth and uhealth · doi:10.2196/24424 · Cited by 66
Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes
Hermanides, J., Phillip, M., & DeVries, J. H. (2011) · Diabetes Care · doi:10.2337/dc11-s219 · Cited by 57
Feasibility study for non-invasive blood glucose monitoring
Freer, B., & Venkataraman, J. (2010) · Digest - IEEE Antennas and Propagation Society. International Symposium · doi:10.1109/aps.2010.5561003 · Cited by 57
Multichannel ECG recording from waist using textile sensors
Alizadeh-Meghrazi, M., Tian, Y., Mahnam, A., Bhattachan, P., Eskandarian, L., Kakhki, S. T., Popović, M. R., & Lankarany, M. (2020) · BioMedical Engineering OnLine · doi:10.1186/s12938-020-00788-x · Cited by 64
Ziegler, C., Liberman, A., Nimri, R., Muller, I., Klemenčič, S., Bratina, N., Bläsig, S., Remus, K., Phillip, M., Battelino, T., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2015/590308 · Cited by 56
Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions
Castle, J. R., & Jacobs, P. G. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816631569 · Cited by 56
Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting
Schnell, O., Barnard, K., Bergenstal, R., Bosi, E., Garg, S., Guerci, B., Haak, T., Hirsch, I. B., Ji, L., Joshi, S. R., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0054 · Cited by 55
Cloud Computing-Based Non-Invasive Glucose Monitoring for Diabetic Care
Pai, P. P., Sanki, P. K., Sahoo, S. K., De, A., Bhattacharya, S., & Banerjee, S. (2017) · IEEE Transactions on Circuits and Systems I Regular Papers · doi:10.1109/tcsi.2017.2724012 · Cited by 63
Hemoglobin A1c—Using Epidemiology to Guide Medical Practice: Kelly West Award Lecture 2020
Selvin, E. (2021) · Diabetes Care · doi:10.2337/dci21-0035 · Cited by 64
Sawayama, J., & Takeuchi, S. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001286 · Cited by 57
Rubin, R. R., & Peyrot, M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300621 · Cited by 54
Petrovski, G., Dimitrovski, Č., Bogoev, M. K., Milenković, T., Ahmeti, I., & Bitovska, I. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0081 · Cited by 59
Bergenstal, R. M., Strock, E. S., Peremislov, D., Gibney, M. A., Parvu, V., & Hirsch, L. J. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.12.014 · Cited by 54
Schaepelynck, P., Darmon, P., Molines, L., Jannot-Lamotte, M.-F., Tréglia, C., & Raccah, D. (2011) · Diabetes & Metabolism · doi:10.1016/s1262-3636(11)70972-7 · Cited by 60
Chamberlain, J. J., Doyle-Delgado, K., Peterson, L., & SKOLNIK, N. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1638 · Cited by 60
Technology Integration: The Role of the Diabetes Care and Education Specialist in Practice
Isaacs, D., Cox, C., Schwab, K., Oser, T. K., Rinker, J., Mason, M. J., Greenwood, D. A., & Albanese-O’Neill, A. (2020) · The Diabetes Educator · doi:10.1177/0145721720935123 · Cited by 53
Automatic Learning Algorithm for the MD-Logic Artificial Pancreas System
Miller, S., Nimri, R., Atlas, E., Grunberg, E. A., & Phillip, M. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0216 · Cited by 53
Juhl, C. B., Højlund, K., Madsen, R. E., Poulsen, M. K., Selmar, P. E., Holst, J. J., Christiansen, C., & Beck‐Nielsen, H. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.007 · Cited by 64
New-generation diabetes management: glucose sensor-augmented insulin pump therapy
Cengiz, E., Sherr, J. L., Weinzimer, S. A., & Tamborlane, W. V. (2011) · Expert Review of Medical Devices · doi:10.1586/erd.11.22 · Cited by 53
The Immunoproteasome: An Emerging Target in Cancer and Autoimmune and Neurological Disorders
Zerfas, B. L., Maresh, M. E., & Trader, D. J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01226 · Cited by 57
An insight into biomimetic 4D printing
Kanu, N. J., Gupta, E., Vates, U. K., & Singh, G. K. (2019) · RSC Advances · doi:10.1039/c9ra07342f · Cited by 55
Severe Hypoglycemia: Is It Still a Threat for Children and Adolescents With Type 1 Diabetes?
Urakami, T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00609 · Cited by 59
Wilmot, E. G., Lumb, A. N., Hammond, P. J., Murphy, H. R., SCOTT, E. M., Gibb, F. W., Platts, J. K., & Choudhary, P. (2020) · Diabetic Medicine · doi:10.1111/dme.14433 · Cited by 57
Metadata
- Authors
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Affiliations
- Yale University (US)
- Corresponding author
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-02
- Volume
- 359
- Issue
- 14
- Pages
- 1464-1476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1531505795
- Semantic Scholar
- b1462f3524589cf66909ea165b57d41352a0293b
- Cited by
- 1,559
- References
- 30
- Citations by year
- 2026: 29 · 2025: 60 · 2024: 64 · 2023: 54 · 2022: 61 · 2021: 103 · 2020: 104 · 2019: 90 · 2018: 109 · 2017: 101 · 2016: 95 · 2015: 85 · 2014: 79 · 2013: 86 · 2012: 104
- FWCI
- 79.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, intensive insulin therapy, HbA1c, glycemic control, age differences, children and adolescents, severe hypoglycemia
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.